Loews Corp’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-300,000
| Closed | -$8.64M | – | 21 |
|
|
2023
Q4 | $8.64M | Buy |
+300,000
| New | +$9.07M | 0.08% | 15 |
|
|
2022
Q1 | – | Sell |
-250,000
| Closed | -$14.8M | – | 61 |
|
|
2021
Q4 | $14.8M | Sell |
250,000
-50,000
| -17% | -$2.48M | 0.13% | 18 |
|
|
2021
Q3 | $12.9M | Buy |
+300,000
| New | +$13.3M | 0.12% | 19 |
|
|
2020
Q1 | – | Sell |
-10,895
| Closed | -$405K | – | 88 |
|
|
2019
Q4 | $405K | Sell |
10,895
-4,028
| -27% | -$143K | ﹤0.01% | 62 |
|
|
2019
Q3 | $509K | Sell |
14,923
-6,767
| -31% | -$246K | ﹤0.01% | 61 |
|
|
2019
Q2 | $891K | Buy |
21,690
+4,136
| +24% | +$164K | 0.01% | 59 |
|
|
2019
Q1 | $707K | Hold |
17,554
| – | – | 0.01% | 69 |
|
|
2018
Q4 | $727K | Sell |
17,554
-5,852
| -25% | -$243K | 0.01% | 75 |
|
|
2018
Q3 | $979K | Hold |
23,406
| – | – | 0.01% | 69 |
|
|
2018
Q2 | $806K | Hold |
23,406
| – | – | 0.01% | 74 |
|
|
2018
Q1 | $788K | Sell |
23,406
-271,237
| -92% | -$9.32M | 0.01% | 74 |
|
|
2017
Q4 | $10.1M | Sell |
294,643
-10,540
| -3% | -$359K | 0.06% | 19 |
|
|
2017
Q3 | $10.3M | Sell |
305,183
-43,772
| -13% | -$1.41M | 0.07% | 23 |
|
|
2017
Q2 | $11.1M | Buy |
348,955
+56,073
| +19% | +$1.77M | 0.07% | 18 |
|
|
2017
Q1 | $9.51M | Sell |
292,882
-44,068
| -13% | -$1.39M | 0.06% | 22 |
|
|
2016
Q4 | $10.4M | Sell |
336,950
-89,590
| -21% | -$2.74M | 0.07% | 21 |
|
|
2016
Q3 | $13.7M | Sell |
426,540
-121,210
| -22% | -$4.05M | 0.11% | 12 |
|
|
2016
Q2 | $18.3M | Sell |
547,750
-395,250
| -42% | -$12.6M | 0.15% | 9 |
|
|
2016
Q1 | $26.5M | Buy |
943,000
+395,250
| +72% | +$11.3M | 0.22% | 9 |
|
|
2015
Q4 | $16.8M | Sell |
547,750
-129,589
| -19% | -$4.08M | 0.13% | 17 |
|
|
2015
Q3 | $20.2M | Buy |
677,339
+75,050
| +12% | +$2.41M | 0.16% | 15 |
|
|
2015
Q2 | $19.2M | Buy |
602,289
+566,440
| +1,580% | +$18.5M | 0.14% | 9 |
|
|
2015
Q1 | $1.18M | Sell |
35,849
-184
| -0.5% | -$5.85K | 0.01% | 68 |
|
|
2014
Q4 | $1.06M | Sell |
36,033
-14,766
| -29% | -$423K | 0.01% | 76 |
|
|
2014
Q3 | $1.43M | Sell |
50,799
-3,936
| -7% | -$110K | 0.01% | 85 |
|
|
2014
Q2 | $1.54M | Buy |
54,735
+15,098
| +38% | +$430K | 0.01% | 87 |
|
|
2014
Q1 | $1.21M | Hold |
39,637
| – | – | 0.01% | 108 |
|
|
2013
Q4 | $1.15M | Sell |
39,637
-7,167
| -15% | -$209K | 0.01% | 110 |
|
|
2013
Q3 | $1.27M | Sell |
46,804
-428,066
| -90% | -$11.6M | 0.01% | 102 |
|
|
2013
Q2 | $12.6M | Buy |
+474,870
| New | +$13.1M | 0.08% | 27 |
|
Other funds holding PFE
Loews Corp's PFE Position: Q1 2024 in Review
Loews Corp sold out of Pfizer (PFE) in Q1 2024, closing a stake of 300,000 shares — an estimated $8.64M sold.
Loews Corp first reported a position in PFE in Q2 2013 and held it in 30 quarters. The position peaked at $26.5M in Q1 2016. 2,874 funds tracked by Wall St. Rank hold PFE as of Q1 2024.
- Loews Corp reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
- Loews Corp sold 300,000 Pfizer shares in Q1 2024, an estimated $8.64M.
- Loews Corp first reported a position in Pfizer in Q2 2013 and held it in 30 quarters.
- Loews Corp's Pfizer position peaked at $26.5M in Q1 2016.
- 2,874 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.
Based on Loews Corp's 13F filing for Q1 2024, filed 6 May 2024.